Oral Complications in Patients with Advanced Cancer

1989 ◽  
Vol 5 (1) ◽  
pp. 7-15 ◽  
Author(s):  
Franco De Conno ◽  
Carla Ripamonti ◽  
Alberto Sbanotto ◽  
Vittorio Ventafridda
Keyword(s):  
Oral Cavity ◽  
Cancer Patient ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Advanced Disease ◽  
Dry Mouth ◽  
Drug Induced ◽  
Oral Complications ◽  
Advanced Phase ◽  
Taste Alteration

Disturbances caused by lesions of the oral cavity play an important part in the alteration of the qualtity of life of cancer patients. The main complications affecting the oral cavity are infections (fungal, viral, bacterial), neutropenic ulcers, drug-induced stomatitis, dry mouth, and taste alteration. Most of the information available about these entities has been acquired in the cancer patient without advanced disease. The little known about the epidemiology and physiopathology of such lesions in the advanced phase of cancer is presented and approaches to management are suggested.

Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients

2015 ◽  
Vol 23 (11) ◽  
pp. 3249-3255 ◽  
Author(s):  
Sebastiano Mercadante ◽  
Federica Aielli ◽  
Claudio Adile ◽  
Patrizia Ferrera ◽  
Alessandro Valle ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Oral Mucositis ◽  
Dry Mouth ◽  
Advanced Cancer Patients

Assessment of Oral Complications in Children Receiving Chemotherapy

2007 ◽  
Vol 31 (4) ◽  
pp. 267-273 ◽  
Author(s):  
Azza El –Housseiny ◽  
Susan Saleh ◽  
Ashraf El –Masry ◽  
Amany Allam
Keyword(s):  
Cancer Patients ◽  
Oral Mucositis ◽  
Pediatric Cancer ◽  
Pediatric Patients ◽  
Standard Dose ◽  
Dry Mouth ◽  
Oral Infections ◽  
Oral Complications ◽  
Oral Pain ◽  
Pediatric Cancer Patients

The aim of this study was to assess the early oral complications in pediatric patients receiving chemotherapy. An interview and oral examination was conducted on 150 pediatric cancer patients receiving standard dose chemotherapy. Results showed that oral pain and dry mouth were the most frequent patients' complaints. The prevalences of chemotherapy-induced oral mucositis and oral infections were relatively high. The chemotherapeutic antimetabolites were the most frequently associated with oral complications than other types of chemotherapy. The present results indicate that the oral complications among patients receiving chemotherapy are common

scholarly journals Pacientes oncológicos com doença avançada: preocupações e expectativas vivenciadas na terminalidade da vida [Cancer patients with advanced disease: concerns and expectations experienced in the terminality of life] [Pacientes com câncer com enfermedad avanzada: preocupaciones y expectativas experimentadas em laterminación de la vida]

2019 ◽  
Vol 27 ◽  
pp. e45650
Author(s):  
Eleandro Do Prado ◽  
Iven Giovanna Trindade Lino ◽  
Patricia Chatalov Ferreira ◽  
Vanessa Carla Batista ◽  
Hellen Pollyanna Mantelo Cecilio ◽  
...  
Keyword(s):  
Palliative Care ◽  
Content Analysis ◽  
Qualitative Study ◽  
Research Ethics ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Advanced Disease ◽  
Well Being ◽  
Positive Probability ◽  
Life Process

Objetivo: evidenciar as preocupações vivenciadas por pacientes com câncer em estágio avançado. Metodologia: estudo qualitativo desenvolvido com 11 pacientes oncológicos em cuidados paliativos. Os dados foram coletados em Maringá – PR, no período de 2016 a 2017, mediante entrevistas abertas, abordando as experiências e enfrentamentos vivenciados durante o processo de terminalidade da vida, das quais foram extraídos os discursos e submetidos à análise de conteúdo após aprovação pelo Comitê de Ética em Pesquisa. Resultados: o medo de tornar-se um incômodo e asincertezas de como a vida continuará após sua partida foram questões hegemônicas dos pacientes, que encontraram na aceitação da morte um momento de reflexão sobre a vida, despontando como uma probabilidade positiva de resiliência e esperança. Conclusão: as principais preocupações manifestadas foram: viver melhor o agora, aproximar-se mais daqueles que lhes fazem bem, preocupando-se com o bem-estar de seus familiares e como eles ficarão após sua partida, transcendendo assim o seu próprio sofrimento.ABSTRACTObjective: to highlight the concerns experienced by patients with advanced cancer. Methodology: qualitative study developed with 11 cancer patients in palliative care. The data were collected in Maringá - PR, from 2016 to 2017, through open interviews, addressing the experiences and confrontations experienced during the terminal life process, from which the speeches were extracted and submitted to content analysis after approval by the Committee Research Ethics. Results: the fear of becoming a nuisance and the uncertainties of how life will continue after his departure, were hegemonic issues of the patients, who found in the acceptance of death a moment of reflection on life, emerging as a positive probability of resilience and hope. Conclusion: the main concerns expressed were: to live better now, to get closer to those who do them well, worrying about the well-being of their families and how they will be after their departure, thus transcending their own suffering.RESUMENObjetivo: resaltar las preocupaciones experimentadas por los pacientes con cáncer avanzado. Metodología: estudio cualitativo desarrollado con 11 pacientes con cáncer en cuidados paliativos. Los datos se recopilaron en Maringá - PR, de 2016 a 2017, a través de entrevistas abiertas, abordando las experiencias y confrontaciones experimentadas durante el proceso de vida terminal, de donde se extrajeron los discursos y se sometieron a análisis de contenido después de la aprobación del Comité Ética de Investigación. Resultados: el miedo a convertirse en una molestia y las incertidumbres de cómo continuará la vida después de su partida, fueron problemas hegemónicos de los pacientes, quienes encontraron en la aceptación de la muerte un momento de reflexión sobre la vida, emergiendo como una probabilidad positiva de resiliencia y Espero Conclusión: las principales preocupaciones expresadas fueron: vivir mejor ahora, acercarse a quienes son buenos para ellos, preocuparse por el bienestar de su familia y cómo estarán después de su partida, trascendiendo así su propio sufrimiento.

The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients

2016 ◽  
Vol 62 (12/2016) ◽  
Author(s):  
Joichi Usui ◽  
Chie Yokoyama ◽  
Masahiro Hagiwara ◽  
Kai Hirayasu ◽  
Takahiro Kojima ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Thrombotic Microangiopathy ◽  
Advanced Cancer Patients ◽  
Drug Induced

Octreotide for the treatment of symptoms of bowel obstruction in advanced cancer

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 19626-19626
Author(s):  
S. Imamura ◽  
S. Maehara
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Bowel Obstruction ◽  
Gastrointestinal Hormones ◽  
Terminal Cancer ◽  
Gi Tract ◽  
Advanced Cancer Patients ◽  
Duration Of Treatment ◽  
Drug Induced ◽  
The Mean

19626 Background: Symptom of bowel obstruction are common and serious complications in terminal advanced cancer patients. Mechanisms of bowel obstructions include intraabdominal carcinomatosis, drug-induced intestinal immobility and intraluminal obstruction. Octreotide inhibits the release of the several gastrointestinal hormones thereby reducing GI tract secretion, and increase the GI tract absorption by slowing down intestinal mobility and decreasing the splanchnic blood flow. Methods: Objectives of this study evaluated efficacy of octreotide in terminal cancer patients with bowel obstruction. We treated all patients with recurrent or advanced cancer admitted to our palliative unit in last 2 years, who had continuous nausea and vomiting related to no surgically bowel obstruction. Octreotide started at a dose of 150 mcg/day in subcutaneous infusion or continuous intravenous infusion, and increase to a dose of 300 mcg/day depending on the symptom. Results: 52 patients with terminal cancer were included in this study. Primary tumor were 13 colon-rectum 13, gastric 8, pancreas 8, biliary tract 4, esophagus 2, gynecological 3 and others 12. The mean age of patients is 71 years of age. All patient have died from tumor progression. The mean dose is 232 mcg/day and the mean duration of treatment is 24 days. 23 patients (45%) were remarkably improved and can take a meal. 15 patients (29%) were improved and diminished vomiting. But 13 patients (25%) remained continuous vomiting. The patient with markedly efficacy lived 2 times longer than other groups. No serious side effects were present. Conclusions: Octreotide shows good efficacy in the management of symptom of malignant obstruction and can be used safely in this population. No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document